All articles by Phillip Broadwith – Page 20
-
Business
Regulator cracks down on 23andMe
Personal genetic profiler ordered to stop selling DNA test kits
-
Business
Pfizer teams up with GSK in cancer drug trial
Two companies will collaborate to develop a combination therapy for melanoma
-
Business
DSM to spin out pharma unit
Firm will combine with Patheon to provide manufacturing services
-
Business
Rapid DNA sequencing cleared for the clinic
Illumina’s ‘next-generation’ MiSeqDx platform gets US approval
-
Business
Novartis sells off blood diagnostics division
$1.7bn deal reinforces firm’s focus on core pharmaceuticals
-
Business
Fracking risks are manageable, says UK industry body
Environmental impact of shale gas exploration should be minimal with proper oversight
-
Business
Shire will cut UK R&D to focus on rare diseases
$4.2bn buyout of ViroPharma bolsters pipeline, while Basingstoke site halts research
-
Business
Vertex to cut 370 jobs
Imminent competition drives drop in its hepatitis C drug’s performance
-
Business
BASF to move pigments production to Asia
Firm will cut 650 jobs, close UK plant and expand in China and Korea
-
Business
Counterfeit anxiety pills seized in Switzerland
1 million fake tablets were en route from China to Egypt
-
Business
Solvay expands surfactants business with Chemlogics buyout
$1.3bn deal brings firm into booming US oil and gas drilling market
-
Business
GSK to apply for malaria vaccine approval
Infection protection drops over time, but the firm will go ahead with regulatory submission
-
Business
Lundbeck cuts jobs in Europe, but expands in US
Depression drug approval fuels US recruitment
-
Business
Aspen acquires anticoagulant brands
South African drugmaker buys thrombosis drugs from GSK for £700m
-
Business
Clariant expands into China
Firm buys pigments arm of Jiangsu Multicolor and will build new plant
-
Business
Algal oil producer steps up supply
Solazyme to provide 10,000 tonnes of tailored oil to Unilever
-
Business
Norway abandons full-scale CCS project
Technology development centre will receive extra funding